Breaking News

SCM Selected for Ketensin Supply

ProStrakan Group has awarded SCM Pharma a five-year contract for the ongoing supply of its licensed product, Ketensin.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ProStrakan Group has awarded SCM Pharma a five-year contract for the ongoing supply of its licensed product, Ketensin. SCM will be responsible for the filling of the 2ml and 10ml vial presentations, sterilization, finished product testing and supply of the product. Ketensin is indicated for the treatment of hypertensive crisis during and after surgery, and is marketed by ProStrakan in the Netherlands. It is a niche product and requires relatively limited supply. David Traynor, senior vice...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters